Diarrhea as a Potential Cause and Consequence of Reduced Gut Microbial Diversity Among Undernourished Children in

Saba Rouhani1, Nicholas W Griffin2,3, Pablo Peñataro Yori1,4

  • 1Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Insights

Diarrhea significantly reduces gut bacterial diversity in children, especially those with severe stunting. A diverse gut microbiota protects against future diarrhea and promotes healthy child growth.

Area of Science:

  • Microbiology
  • Pediatric Health
  • Nutritional Science

Background:

  • Diarrhea negatively impacts child growth and survival, with mechanisms poorly understood.
  • Early-life gut microbiota development is linked to growth faltering and disease susceptibility.
  • This study investigates the interplay between diarrhea, gut microbiota, and child growth in the Peruvian Amazon.

Purpose of the Study:

  • To assess the association between diarrhea, gut microbiota composition, and child growth.
  • To determine if gut microbiota alterations are linked to diarrhea risk.
  • To understand the impact of growth faltering on gut microbiota resilience.

Main Methods:

  • A birth cohort of 271 children (0-24 months) was monitored monthly for growth, diarrhea, and other health factors.
  • Fecal samples were collected at 6, 12, 18, and 24 months for 16S rRNA gene sequencing to analyze gut bacterial diversity and taxa.
  • Statistical models were used to link diarrhea, microbiota features, and growth parameters.

Main Results:

  • Diarrheal frequency, duration, and severity were negatively correlated with gut bacterial diversity and richness.
  • Severely stunted children showed the most significant reductions in bacterial diversity and slower recovery post-diarrhea.
  • Higher bacterial diversity predicted a lower risk of subsequent diarrhea between 6 and 18 months of age.

Conclusions:

  • Severe growth faltering may impair the gut microbiota's ability to resist and recover from diarrhea.
  • Reduced gut microbiota diversity and resilience increase the risk of recurrent diarrhea and further growth faltering.
  • Restoring gut microbiota health is crucial for preventing childhood diarrhea and promoting optimal growth.
Abstract

Related Concept Videos

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents01:18

Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents

Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
386
Fungal Phylum Microsporidia01:28

Fungal Phylum Microsporidia

Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
354
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents01:20

Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents

Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
536
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
581
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
567
Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents01:17

Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents

Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
570